Promethium Advisors »

Eli Lilly & Co. shares owned by Promethium Advisors

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by Promethium Advisors from 13F filings

Historical chart of Promethium Advisors investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by Promethium Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by Promethium Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $886k 1.0k 885.94

More positions owned by Promethium Advisors

Apple (AAPL)
Thomson Reuters Corp. (TRI)
Pfizer (PFE)
Bristol Myers Squibb (BMY)
Broadstone Net Lease (BNL)
T. Rowe Price (TROW)
Texas Pacific Land Corp (TPL)
Alphabet Cap Stk Cl A (GOOGL)
Danaher Corporation (DHR)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Cme (CME)
Ishares Tr U.s. Tech Etf (IYW)
Johnson & Johnson (JNJ)
Spdr Ser Tr Bloomberg 3-12 M (BILS)

View all positions for Promethium Advisors

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
BlackRock
Pnc Financial Services
State Street Corporation
T. Rowe Price Associates
Capital World Investors
Jpmorgan Chase & Co
PRIMECAP Management Company
Geode Capital Management
Morgan Stanley
State Farm Mutual Automobile Insurance Company
International Assets Investment Management
Bank of America Corporation

View all funds holding Eli Lilly & Co.